Stock Scorecard
Stock Summary for Stryker Corp (SYK) - $364.50 as of 3/28/2025 9:06:14 PM EST
Total Score
8 out of 30
Safety Score
65 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SYK
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SYK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SYK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SYK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for SYK (65 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SYK
Financial Details for SYK
Company Overview |
|
|---|---|
| Ticker | SYK |
| Company Name | Stryker Corp |
| Country | USA |
| Description | Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 4/28/2025 |
Stock Price History |
|
| Last Day Price | 364.50 |
| Price 4 Years Ago | 258.96 |
| Last Day Price Updated | 3/28/2025 9:06:14 PM EST |
| Last Day Volume | 1,273,285 |
| Average Daily Volume | 1,474,039 |
| 52-Week High | 406.19 |
| 52-Week Low | 313.50 |
| Last Price to 52 Week Low | 16.27% |
Valuation Measures |
|
| Trailing PE | 47.36 |
| Industry PE | 64.12 |
| Sector PE | 40.10 |
| 5-Year Average PE | 28.66 |
| Free Cash Flow Ratio | 30.97 |
| Industry Free Cash Flow Ratio | 29.26 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 1.95 |
| Total Cash Per Share | 11.77 |
| Book Value Per Share Most Recent Quarter | 54.10 |
| Price to Book Ratio | 6.80 |
| Industry Price to Book Ratio | 5.12 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 6.21 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.27 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 13 |
| Analyst Strong Buy Ratings | 9 |
Share Statistics |
|
| Total Shares Outstanding | 381,689,000 |
| Market Capitalization | 139,125,640,500 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 3/31/2025 |
| Previous Dividend Amount | 0.8400 |
| Current Dividend Amount | 0.8400 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 3.24 |
| Trailing Annual Dividend Yield | 0.87% |
| Forward Annual Dividend Rate | 3.36 |
| Forward Annual Dividend Yield | 0.90% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 0.90% |
| 5-Year Average Dividend Yield | 1.03% |
| 1-Year Dividend Growth Rate Percentage | 3.70% |
| 3-Year Dividend Growth Rate Percentage | 1.84% |
| 5-Year Dividend Growth Rate Percentage | 6.78% |
| All-Time Dividend Growth Rate Percentage | 12.41% |
| Dividend Payout Ratio | 42.19% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -52.60% |
| Annual Earnings Growth | -5.43% |
| Reported EPS 12 Trailing Months | 7.76 |
| Reported EPS Past Year | 12.19 |
| Reported EPS Prior Year | 10.60 |
| Net Income Twelve Trailing Months | 2,993,000,000 |
| Net Income Past Year | 2,993,000,000 |
| Net Income Prior Year | 3,165,000,000 |
| Quarterly Revenue Growth YOY | 10.70% |
| 5-Year Revenue Growth | 8.71% |
| Operating Margin Twelve Trailing Months | 25.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 4,493,000,000 |
| Total Cash Past Year | 4,493,000,000 |
| Total Cash Prior Year | 3,053,000,000 |
| Net Cash Position Most Recent Quarter | -9,219,000,000 |
| Net Cash Position Past Year | -9,219,000,000 |
| Long Term Debt Past Year | 13,712,000,000 |
| Long Term Debt Prior Year | 13,080,000,000 |
| Total Debt Most Recent Quarter | 13,712,000,000 |
| Equity to Debt Ratio Past Year | 0.60 |
| Equity to Debt Ratio Most Recent Quarter | 0.60 |
| Total Stockholder Equity Past Year | 20,634,000,000 |
| Total Stockholder Equity Prior Year | 18,593,000,000 |
| Total Stockholder Equity Most Recent Quarter | 20,634,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 3,487,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 9.14 |
| Free Cash Flow Past Year | 3,487,000,000 |
| Free Cash Flow Prior Year | 3,136,000,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -3.76 |
| MACD Signal | -3.18 |
| 20-Day Bollinger Lower Band | 359.64 |
| 20-Day Bollinger Middle Band | 379.61 |
| 20-Day Bollinger Upper Band | 399.57 |
| Beta | 0.96 |
| RSI | 47.67 |
| 50-Day SMA | 357.81 |
| 150-Day SMA | 294.29 |
| 200-Day SMA | 283.86 |
System |
|
| Modified | 3/28/2025 8:40:21 AM EST |